Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2003
12/11/2003CA2486803A1 Process for preparing vinylaromatic compounds
12/10/2003EP1369464A2 Flame retardant treating agents, flame retardant treating process and flame retardant treated articles
12/10/2003EP1369445A1 Curing accelerator, epoxy resin composition, and semiconductor device
12/10/2003EP1369422A1 Process for preparation of alkenylphosphine oxides or alkenylphosphinic acid esters
12/10/2003EP1368389A1 Complexed compounds and use thereof for the polymerisation of olefins
12/10/2003EP1368362A1 Ascorbic acid 2-phosphate metal salt with low calcium content
12/10/2003EP1368361A1 Derivative of phosphoric acid ester salt or phosphoric acid ester adduct or mixtures thereof, method for the production thereof and their use
12/10/2003EP1368360A2 Zwitterionic gemini surfactants for use in carbon dioxide
12/10/2003EP1185276B1 Isophosphoramide mustard analogs and use thereof
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP1053219B1 Improved separation processes
12/10/2003EP0998518B1 Process for the preparation of polyether phosphates
12/10/2003EP0796264B1 Process for the preparation of phosophoric monoester
12/10/2003CN1460682A Method of synthesizing bridged oxyalkylcyclotriphosphonitrile compound
12/10/2003CN1460681A Production process of vitamin C-2-phosphate ester magnesium
12/10/2003CN1130367C Phosphoric ester, process for preparing the same and use thereof
12/10/2003CN1130366C Substituted phenylketoenols and preparing method, midbody and their use as pestcides and herbicides
12/09/2003US6660878 Reacting a hexahydrotriazine compound with a triacyl phosphite, and to intermediates for use in this
12/09/2003US6660876 Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
12/09/2003US6660874 Trialkyl Group VA metal compounds
12/09/2003US6660860 Process for the selective oxidation of alcohols using readily removable nitroxyl radicals
12/09/2003US6660785 Self-adhesive polymerizable monomer and dental/medical compositions therefrom
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660724 Compounds and pharmaceutical compositions containing them
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660696 Thermally stable phosphorothionates as antioxidant, antiwear, friction reducing and extreme pressure lubricant additives from cashew nut shell liquid
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/09/2003US6660529 Heteroaryl substituted benzothiazole dioxetanes
12/09/2003US6660494 Detecting phosphatidylcholine-specific phospholipase-C enzyme via incorporation of 3-indoxyl choline phosphate into substrate
12/09/2003US6660331 MOCVD of SBT using toluene-based solvent system for precursor delivery
12/04/2003WO2003100073A2 Method for producing phosphoric acid triesters
12/04/2003WO2003099832A1 Hydroxy diphosphines and their use in catalysis
12/04/2003WO2003099831A1 Continuous process for preparing n-phosphonomethyl glycine
12/04/2003WO2003099830A2 Cardiolipin compositions, methods of preparation and use
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099435A2 Catalyst and process for the cyanation of aldehydes
12/04/2003WO2003099195A2 Immunomodulatory compounds and methods of use thereof
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003082881A3 Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
12/04/2003WO2003078626A3 A building block capable of transferring a functional entity
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2002068678A3 Beta-lactamase substrates having phenolic ethers
12/04/2003US20030225298 Reacting bis-(phosophonomethyl)urea or urea with carbon monoxide and formaldehyde in the presence of catalysts and solvents to form N-(phosphonomethyl)glycine
12/04/2003US20030225297 Process for preparing chiral diphosphines
12/04/2003US20030225284 Process for manufacturing purified phosphorodiamidite
12/04/2003US20030225277 9-(2-(2,4-cis(S)-4-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphor-inan-2 -yl)methoxyethyl)adenine by coupling the dichloridate of 9-(2-phosphonyl- methoxyethyl- or propyl)adenine (PMEA)(PMPA) with a 1-(chlorophenyl) propylene-1,3-diol
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225244 Poly (alkylene oxide) prepared in the presence of a phosphazenium salt or compound
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225226 Reacting suitable equivalents of a compound of formula X2P-A-PX2 (1H) (X=Cl, Br, I) with a compound of dicyclopentadienezirconium compound to form a ligand which complexed with a transition metal compound to form complex
12/04/2003US20030225195 Silicon compounds such as 2-triethoxysilyl-1-ethylthioacetate, used as binders of rubbers such as butadiene-styrene copolymers, containing fillers
12/04/2003US20030225192 Mxitures of 2-(2-hydroxy-4(3-butoxy-2-hydroxypropyloxy)-phenyl )-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine and hindered amine light stabilizers, used for stabilization of curable polycarbonates
12/04/2003US20030225040 Selective androgen receptor modulators and methods of use thereof
12/04/2003US20030225035 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
12/04/2003US20030222023 Shaped bodies containing metal-organic frameworks
12/04/2003CA2487295A1 Catalyst and process for the cyanation of aldehydes
12/04/2003CA2486967A1 Cardiolipin compositions their methods of preparation and use
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/03/2003EP1367046A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
12/03/2003EP1366055A2 Antiviral agents for treatment of flaviviridae infections
12/03/2003EP1366053A1 Flame-proofing agents
12/03/2003EP1366048A2 Pyrazolopyridine derivatives
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366004A2 Catalytic hydrogenation processes
12/03/2003EP1311515A4 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
12/03/2003EP1123301B1 Chelating agents for radioimmunotherapy
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003CN1459454A Preparation method of phosphorus containing trifunctional group liquid alicyclic epoxide compound
12/03/2003CN1459453A Phosphate type liquid alicyclic olefin compound and its preparation method
12/03/2003CN1459452A Phosphite type liquid alicyclic olefin compound and its preparation method
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129428C Endothelin receptor antagonists
12/02/2003US6657081 Calixarene derivatives
12/02/2003US6657076 Hydrolysing the corresponding acid hydrochloric acid; water removal; salt formation with amine or base
12/02/2003US6657064 For use as analgesics
12/02/2003US6657043 Polyalcoxyamines obtained from β-substituted nitroxides
12/02/2003US6657027 Compounds in which a transition metal is complexed with two ligand systems that systems are reversibly bonded together by a bridge ofa donor and an acceptor; at least one fluorinated aryl radical; olefin polymerization catalysts
12/02/2003US6656958 Substituted pyridine compounds useful for controlling chemical synaptic transmission
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656927 Ip3 receptor ligands
12/02/2003US6656926 Phosphoramide compounds
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
12/02/2003US6656868 For olefin in gas or slurry phase using spray dried catalyst
12/02/2003US6656448 Matrix metalloproteinase inhibitors
12/02/2003US6656446 Using carbon dioxide soluble secondary alcohol, free radical initiator and oxygen in carbon dioxide
12/02/2003CA2118007C Phosphonic diester derivative
12/02/2003CA2085171C Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use
11/2003
11/30/2003CA2429058A1 Method of producing oxybutynin and its derivatives
11/27/2003WO2003097856A2 Plating media
11/27/2003WO2003097792A2 Polypeptide immobilization
11/27/2003WO2003097655A1 Use of certain diluents for making bisphosphonic acids
11/27/2003WO2003097654A1 Method for producing an alkenyl phosphorus compound
11/27/2003WO2003097653A1 Compound and processes for the preparation and use thereof
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003069302A3 Alpha-substituted arylalkyl phosphonate derivatives
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 554